Form 8-K - Current report:
SEC Accession No. 0000200406-25-000152
Filing Date
2025-06-10
Accepted
2025-06-10 17:06:51
Documents
16
Period of Report
2025-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20250610.htm   iXBRL 8-K 41877
2 EX-99 ex991-pressrelease.htm EX-99 9018
7 image_0.jpg GRAPHIC 244
8 image_1.jpg GRAPHIC 19328
  Complete submission text file 0000200406-25-000152.txt   298859

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20250610.xsd EX-101.SCH 4583
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20250610_def.xml EX-101.DEF 10568
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20250610_lab.xml EX-101.LAB 38371
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20250610_pre.xml EX-101.PRE 22234
18 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20250610_htm.xml XML 10683
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 251037946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)